hinge health inc - HNGE

HNGE

Close Chg Chg %
38.51 0.47 1.21%

Closed Market

38.97

+0.47 (1.21%)

Volume: 475.96K

Last Updated:

Apr 2, 2026, 3:59 PM EDT

Company Overview: hinge health inc - HNGE

HNGE Key Data

Open

$37.24

Day Range

37.06 - 39.27

52 Week Range

N/A - N/A

Market Cap

$3.07B

Shares Outstanding

78.76M

Public Float

26.83M

Beta

1.81

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$5.44

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.02M

 

HNGE Performance

1 Week
 
7.53%
 
1 Month
 
-15.52%
 
3 Months
 
-14.44%
 
1 Year
 
N/A
 
5 Years
 
N/A
 

HNGE Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 16
Full Ratings ➔

About hinge health inc - HNGE

Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. It leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for its clients. The firm has designed its platform to address a broad spectrum of MSK care, ranging from acute injury, to chronic pain, to post-surgical rehabilitation, and the platform can help to ease members’ pain, improve their function, and reduce their need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere. The company was founded by Daniel Perez and Gabriel Mecklenburg in 2014 and is headquartered in San Francisco, CA.

HNGE At a Glance

Hinge Health, Inc.
455 Market Street
San Francisco, California 94105
Phone 1-415-726-2206 Revenue 587.86M
Industry Packaged Software Net Income -424,087,000.00
Sector Technology Services 2025 Sales Growth 50.577%
Fiscal Year-end 12 / 2026 Employees 143
View SEC Filings

HNGE Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 6.256
Price to Book Ratio 20.584
Price to Cash Flow Ratio 21.45
Enterprise Value to EBITDA -6.571
Enterprise Value to Sales 5.99
Total Debt to Enterprise Value 0.002

HNGE Efficiency

Revenue/Employee 4,110,909.091
Income Per Employee -2,965,643.357
Receivables Turnover 8.899
Total Asset Turnover 0.827

HNGE Liquidity

Current Ratio 1.387
Quick Ratio 1.29
Cash Ratio 1.004

HNGE Profitability

Gross Margin 79.649
Operating Margin -92.032
Pretax Margin -89.692
Net Margin -72.141
Return on Assets -59.652
Return on Equity -106.657
Return on Total Capital -109.704
Return on Invested Capital -105.192

HNGE Capital Structure

Total Debt to Total Equity 2.124
Total Debt to Total Capital 2.08
Total Debt to Total Assets 1.077
Long-Term Debt to Equity 2.136
Long-Term Debt to Total Capital 0.987
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Hinge Health Inc - HNGE

Collapse All in section
All values USD millions. 2023 2024 2025 5-year trend
Sales/Revenue
- 292.73M 390.40M 587.86M
Sales Growth
- - +33.37% +50.58%
-
Cost of Goods Sold (COGS) incl D&A
- 98.55M 89.81M 119.64M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- 5.63M 5.95M 5.13M
Depreciation
- 5.23M 5.55M 4.23M
Amortization of Intangibles
- 400.00K 400.00K 900.00K
COGS Growth
- - -8.87% +33.21%
-
Gross Income
- 194.18M 300.59M 468.22M
Gross Income Growth
- - +54.80% +55.77%
-
Gross Profit Margin
- +66.33% +77.00% +79.65%
2023 2024 2025 5-year trend
SG&A Expense
- 324.69M 325.02M 1.01B
Research & Development
- 110.06M 97.49M 368.14M
Other SG&A
- 214.63M 227.53M 641.11M
SGA Growth
- - +0.10% +210.51%
-
Other Operating Expense
- - - -
-
Unusual Expense
- - 7.48M 5.35M
-
EBIT after Unusual Expense
- (130.51M) (31.91M) (546.37M)
Non Operating Income/Expense
- 21.97M 20.65M 19.11M
Non-Operating Interest Income
- - - 18.68M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
- (108.55M) (11.26M) (527.26M)
Pretax Income Growth
- - +89.63% -4,584.28%
-
Pretax Margin
- -37.08% -2.88% -89.69%
Income Tax
- (405.00K) 677.00K 998.00K
Income Tax - Current - Domestic
- - 624.00K 471.00K
-
Income Tax - Current - Foreign
- 68.00K 638.00K 474.00K
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- (473.00K) (585.00K) 53.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - 104.17M
-
Consolidated Net Income
- (108.14M) (11.93M) (424.09M)
Minority Interest Expense
- - - -
-
Net Income
- (108.14M) (11.93M) (424.09M)
Net Income Growth
- - +88.97% -3,453.90%
-
Net Margin Growth
- -36.94% -3.06% -72.14%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
- (108.14M) (11.93M) (424.09M)
Preferred Dividends
- - - -
-
Net Income Available to Common
- (108.14M) (11.93M) (424.09M)
EPS (Basic)
- -1.3861 -0.153 -5.3566
EPS (Basic) Growth
- - +88.96% -3,401.05%
-
Basic Shares Outstanding
- 78.02M 78.02M 79.17M
EPS (Diluted)
- -1.3861 -0.153 -5.3566
EPS (Diluted) Growth
- - +88.96% -3,401.05%
-
Diluted Shares Outstanding
- 78.02M 78.02M 79.17M
EBITDA
- (124.89M) (18.48M) (535.89M)
EBITDA Growth
- - +85.20% -2,799.98%
-
EBITDA Margin
- -42.66% -4.73% -91.16%

Snapshot

Average Recommendation BUY Average Target Price 57.867
Number of Ratings 16 Current Quarters Estimate 0.442
FY Report Date 06 / 2026 Current Year's Estimate 1.94
Last Quarter’s Earnings 0.40 Median PE on CY Estimate N/A
Year Ago Earnings 2.62 Next Fiscal Year Estimate 2.291
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 13 13 13 13
Mean Estimate 0.44 0.48 1.94 2.29
High Estimates 0.50 0.52 2.50 3.09
Low Estimate 0.37 0.42 1.60 1.86
Coefficient of Variance 8.33 6.30 10.81 12.84

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 13 13 14
OVERWEIGHT 2 2 2
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Hinge Health Inc - HNGE

Date Name Shares Transaction Value
Feb 20, 2026 Deer Management Co. LLC Director N/A Open market or private sale of non-derivative or derivative security 0.00
Feb 20, 2026 Deer Management Co. LLC Director N/A Open market or private sale of non-derivative or derivative security 0.00

Hinge Health Inc in the News